The clinical importance of dynamic lung hyperinflation in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 3, Issue 4, 2006, Pages 219-232

  O'Donnell, Denis E ^a,b   Laveneziana, Pierantonio ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Bronchodilators; COPD; Dynamic hyperinflation; Dyspnea; Exercise capacity; Heliox; Oxygen; Respiratory mechanics; Spirometry

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; HELIOX; HELIUM; IPRATROPIUM BROMIDE; OXITROPIUM BROMIDE; OXYGEN; PLACEBO; SALBUTAMOL; TIOTROPIUM BROMIDE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DYSPNEA; ELECTRON TRANSPORT; EXERCISE; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESIDUAL VOLUME; REVIEW; SARCOMERE; SINGLE DRUG DOSE; SPIROMETRY; SYMPTOMATOLOGY; TIDAL VOLUME; TOTAL LUNG CAPACITY; VITAL CAPACITY;

BRONCHODILATOR AGENTS; EXERCISE; EXERCISE THERAPY; FORCED EXPIRATORY FLOW RATES; HUMANS; OXYGEN INHALATION THERAPY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RESPIRATORY MECHANICS; REST; SPIROMETRY;

EID: 33845620271     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550600977478     Document Type: Review

References (105)

1. Stokes W. A treatise on the diagnosis and treatment of diseases of the chest. Part 1. Diseases of the lung and windpipe. London: The New Sydenham Society, 1837; 168-169.
2. Sharp JT. The respiratorymuscles in emphysema. Clin Chest Med 1983; 4:421-432.
3. Sharp JT, Goldberg NB, Druz WS, Fishman HC, Danon J. Thoraco-abdominal motion in chronic obstructive lung disease. Am Rev Resp Dis 1977; 115:47-56.
4. Simon G. Principles of Chest X-ray Diagnosis, 3rd ed. London: Butterworths, 1971.
5. Simon G, Pride NB, Jones NL, Raimondi AC. Relation between abnormalities in the chest radiograph and changes in pulmonary function in chronic bronchitis and emphysema. Thorax 1973; 28:15-23.
6. Burki NK, Krumpelman JL. Correlation of pulmonary function with the chest roentgenogram in chronic airway obstruction. Am Rev Respir Dis 1980; 121:217-223.
7. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Parè PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102-1108.
8. de Jong PA, Müller NL, Paré PD, Coxson HO. Computed tomographic imaging of the airways:relationship to structure and function. Eur Respir J 2005 26:140-152.
9. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. ATS/ERS Task Force: Standardisation of lung function testing: Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968.
10. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6:Suppl. 16, 5-40.
11. He Z, Lam M, Webb K, O'Donnell DE. Ventilatory Constraints during Exercise in Patients with Mild COPD. Am J Respir Crit Care Med 2005; 171:A304.
12. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J 1999;13:468-472.
13. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12:799-804.
14. O'Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med 2001; 164:770-777.
15. Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitations at rest. Eur Respir J 2000; 16:269-275.
16. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005 15; 171:591-597.
17. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1557-1565.
18. O'Donnell DE, He Z, Lam M, Webb K, Fluge T, Hamilton A. Reproducibility of measurements in inspiratory capacity, dyspnea intensity and exercise endurance inmulticentre trials in COPD (abs). Eur Respir J 2004; 24(48):P2151.
19. O'Donnell D, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23:832-840.
20. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, Kesten S, O'Donnell D. Improvements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPD. Chest 2005; 128:1168-1178.
21. Hyatt RE. Expiratory flow limitation. J Appl Physiol 1983; 55:1-8.
22. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow - a unifying concept. J Appl Physiol 1977; 43:498-515.
23. Pride NB. Ageing and changes in lung mechanics. Eur Respir J 2005; 26:563-565.
24. Pride NB, Macklem PT. Lung mechanics in disease. In: Fishman AP, ed. Handbook of Physiology, Section 3, Vol III, Part 2: The Respiratory System. Bethesda, MD: American Physiological Society, 1986; 659-692.
25. Vinegar A, Sinnett EE, Leith DE. Dynamic mechanisms determine functional residual capacity in mice. J Appl Physiol 1979; 46:867-891.
26. Sharp JT. The respiratory muscles in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134:1089-1091.
27. Demedts M. Mechanisms and consequences of hyperinflation. Eur Respir J 1990; 3:617-618.
28. Macklem PT. Hyperinflation (editorial). Am Rev Respir Dis 1984; 129:1-2.
29. Lougheed DM, Webb KA, O'Donnell DE. Breathlessness during induced lung hyperinflation in asthma:the role of the inspiratory threshold load. Am J Respir Crit Care Med 1995; 152:911-920.
30. Cormier Y. Mechanisms of hyperinflation in asthma. Eur Respir J 1990; 3:619-624.
31. Martin JG. Inspiratory muscle activity during induced hyperinflation. Respir Physiol 1980; 39:303-313.
32. Cole P, Savard P, Miljeteig H, Haight JS. Resistance to respiratory airflow of the extrapulmonary airways. Laryngoscope 1993; 103(4 Pt. 1):447-450.
33. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:1510-1516.
34. O'Donnell DE, Parker CM. COPD exacerbations·3: Pathophysiology. Thorax 2006; 61:354-361.
35. Gelb AF, Guitierrez CA, Weisman IM, Newsom R, Taylor CF, Zamel N. Simplified detection of dynamic hyperinflation. Chest 2004; 126:1855-1860.
36. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:892-898.
37. Grimby G, Bunn J, Mead J. Relative contribution of rib cage and abdomen to ventilation during exercise. J Appl Physiol 1968; 24:159-166.
38. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest 1971; 50:910-919.
39. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49:511-515.
40. Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic airway obstruction. Am Rev Respir Dis 1984; 129:33-38.
41. Aliverti A, Stevenson N, Dellaca RL, Lo Mauro A, Pedotti A, Calverley PM. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004; 59:210-216.
42. Clarenbach CF, Senn O, Brack T, Kohler M, Bloch KE. Monitoring of ventilation during exercise by a portable respiratory inductive plethysmograph. Chest 2005; 128:1282-1290.
43. Vogiatzis I, Georgiadou O, Golemati S, Aliverti A, Kosmas E, Kastanakis E, Geladas N, Koutsoukou A, Nanas S, Zakynthinos S, Roussos C. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 2005; 60:723-729.
44. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991; 325:917-923.
45. Orozco-Levi M, Gea J, Lloreta JL, Félez M, Minguella J, Serano S, Broquetas JM. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13:371-378.
46. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphgram in chronic obstructive pulmonary disease. N Engl J Med 1997; 337:1799-1806.
47. Mercadier JJ, Schwartz K, Schiaffino S, Wisnewsky C, Ausoni S, Heimburger M, Marrash R, Pariente R, Aubier M. Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol 1998; 274:L527-534.
48. Decramer M. Hyperinflation and respiratory muscle interaction. Eur Respir J 1997; 10:934-941.
49. O'Donnell DE, Webb KA. Exercise. In: Calverley PMA, MacNee W, Pride NB, Rennard SI, eds. Chronic Obstructive Pulmonary Disease, 2nd edition. London: Arnold, 2003; Chapter 18:243-269.
50. O'Donnell DE, Chau LKL, Bertley JC, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109-115.
51. Sinderby C, Spahija J, Beck J, Kaminski D, Yan S, Comtois N, Sliwinski P. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1637-1641.
52. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise Hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002; 166:663-668.
53. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154:1284-1289.
54. Light RW, Mintz WM, Linden GS, Brown SE. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1984; 130:391-395.
55. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113:576-583.
56. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006; 101:1025-1035.
57. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD. Am J Respir Crit Care Med 1999; 160:524-549.
58. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:967-975.
59. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24:86-94.
60. O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130:647-656.
61. Peters MM, Webb KA, O'Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnea in normoxic COPD. Thorax 2006; 61:559-567.
62. O'Donnell DE, Bertley J, Webb KA, Conlan AA. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in advanced chronic airflow limitation. Chest 1996; 110:18-27.
63. Martinez FJ, Montes de Oca M, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med 1997; 155:1984-1990.
64. Laghi F, Jurban A, Topeli A, Fahey PJ, Garrity Jr E, Archids JM, DePinto DJ, Edwards LC, Tobin MJ. Effect of lung volume reduction surgery on neuromechanical coupling of the diaphragm. Am J Respir Crit Care Med 1998; 157:475-483.
65. Barbera JA, Roca J, Ferrer A, Felez MA, Diaz O, Roger N, Rodriguez-Roisin R. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1285-1291.
66. Calverley PM. Respiratory failure in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003; 47:26s-30s.
67. Tantucci C, Corbeil C, Chasse M, Braidy J, Matar N, Milic-Emili J. Flow resistance in patients with chronic obstructive pulmonary disease in acute respiratory failure. Am Rev Respir Dis 1991; 144:384-389.
68. Guerin C, Coussa ML, Eissa NT, Corbeil C, Chasse M, Braidy J, Matar N, Milic-Emili J. Lung and chest wall mechanics in mechanically ventilated COPD patients. J Appl Physiol 1993; 74:1570-1580.
69. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Resp J 2005; 26:420-428.
70. O'Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD. Is spirometry useful? Chest 2000; 117:42S-47S.
71. Newton M, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121:1042-1050.
72. Rabe KF, Bateman ED, O'Donnell D, Witte S, Bredenbröker D, Bethke TD. Roflumilast - an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2005; 366:563-571.
73. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162:917-919.
74. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 124:1743-1748.
75. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible emphysema." Eur Respir J 2001; 18:914-920.
76. Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorscan J III, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996; 334:1095-1099.
77. Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. Brit Med J 1988; 297:1506-1510.
78. van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, Cornellisen PJG. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006; 129:509-517.
79. Gandevia SC. The perception of motor commands on effort during muscular paralysis. Brain 1982; 105:151-195.
80. Chen Z, Eldridge FL, Wagner PG. Respiratory associated rhythmic firing of midbrain neurons in cats:relation to level of respiratory drive. J Physiol 1991; 437:305-325.
81. Campbell EJM, Howell JBL. The sensation of breathlessness. Br Med Bull 1963; 18:36-40.
82. Chen Z, Eldridge FL, Wagner PG. Respiratory-associated thalamic activity is related to level of respiratory drive. Respir Physiol 1992; 90:99-113.
83. O'Donnell DE, Hong HH, Webb KA. Respiratory sensation during chest wall restriction and dead space loading in exercising men. J Appl Physiol 2000; 88:1859-1869.
84. Davenport PW, Friedman WA, Thompson FJ, Franzen O. Respiratory-related cortical potentials evoked by inspiratory occlusion in humans. J Appl Physiol 1986; 60:1843-1848.
85. Zechman FR Jr., Wiley RL. Afferent inputs to breathing: respiratory sensation: In: AP Fishman, ed. Handbook of Physiology, Section 3, Volume II, Part 2: The Respiratory System. Bethesda, MD: American Physiological Society, 1986; 449-474.
86. Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci 1988; 74:531-537.
87. Lane R, Cockcroft A, Adams L, Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci 1987; 72:693-698.
88. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers." Lancet 1981; 1:907-909.
89. Stein DA, Bradley BL, Miller W. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 1982; 81:6-10.
90. Libby DM, Briscoe WA, King TKC. Relief of hypoxia-related bronchoconstriction by breathing 30 percent oxygen. Am Rev Respir Dis 1981; 123:171-175.
91. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155:530-535.
92. Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxemic COPD patients. Eur Respir J 2001; 18:77-84.
93. Barach AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935; 9:739-765.
94. Pedley TJ, Schroter RC, Sudlow MF. Gas flow and mixing in the airways. West JB, ed. Bioengineering aspects of the lung. New York: Marcel Dekker, 1977; 163-265.
95. Grapé B, Channin E, Tyler JM. The effect of helium and oxygen mixtures on pulmonary resistances in emphysema. Am Rev Respir Dis 1960; 81:823-829.
96. Wouters EF, Landser FJ, Polko AH, Visser BF. Impedance measurement during air and helium-oxygen breathing before and after salbutamol. Clin Exp Pharmacol Physiol 1992; 19:95-101.
97. Swidwa DM, Montenegro HD, Goldman MD, Lutchen KR, Saidel GM. Helium-oxygen breathing in severe chronic obstructive pulmonary disease. Chest 1985; 87:790-795.
98. Meadows JA 3rd, Rodarte JR, Hyatt RE. Density dependence of maximal expiratory flow in chronic obstructive pulmonary disease. Am Rev Respir Dis 1980; 121:47-53.
99. Marini JJ. Heliox in chronic obstructive pulmonary disease: time to lighten up? Crit Care Med 2000; 28:3086-3088.
100. Chevrolet JC. Helium oxygen mixtures in the intensive care unit. Crit Care 2001; 5:179-181.
101. McClaran SR, Wetter TJ, Pegelow DF, Dempsey JA. Role of expiratory flow limitation in determining lung volumes and ventilation during exercise. J Appl Physiol 1999; 86:1357-1366.
102. Palange P, Valli G, Onorati P, Antonucci R, Paoletti P, Rosato A, Manfredi F, Serra P. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97:1637-1642.
103. Goto S, Porszasz J, Sakurai S, et al. Effect of helium breathing on dynamic hyperinflation, minute ventilation and exercise tolerance in severe COPD patients. Am J Respir Crit Care Med 2004; 169:467A.
104. Laude EA, Duffy NC, Baveystock C, Dougill B, Campbell MJ, Lawson R, Jones PW, Calverley PM. The effect of helium and oxygen on exercise performance in COPD: a randomised crossover trial. Am J Respir Crit Care Med 2006; 173:865-870.
105. O'Donnell DE, Webb KA. Mechanisms of dyspnea in COPD. In: Mahler D, O'Donnell DE (eds.). Dyspnea: Mechanisms, Measurement, and Management, 2nd edition. Lung Biology in Health and Disease Series, Volume 208, Chapter 3. Boca Raton, FL: Taylor & Francis Group, 2005; pp. 29-58.